Internal Medicine, Gastroenterology · Indianapolis, IN
NPI
1386774172
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1701 N Senate Blvd
Indianapolis, IN, 46202
Phone (888) 484-3258
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
478 services
Medicare patients, 2024
160
Average age 69
Drug cost, 2024
$363K
1,445 prescriptions
Company payments, 2025
$1,250
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marco A Lacerda was code 99214 (office e&m - established), 168 times for 115 patients. In total Marco A Lacerda billed 478 services in 10 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 168 | 115 | $64.55 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 135 | 101 | $11.86 | $1,602 |
| 99232 Hospital E&M - Subsequent | Facility | 65 | 28 | $56.25 | $3,656 |
| 99233 Hospital E&M - Subsequent | Facility | 50 | 16 | $85.12 | $4,256 |
| 99213 Office E&M - Established | Facility | 20 | 20 | $41.30 | $826 |
| 99239 Hospital Discharge Management | Facility | 14 | 11 | $81.82 | $1,146 |
| 99223 Hospital E&M - Initial | Facility | 14 | 14 | $122.53 | $1,715 |
By year: 2022 $24K for 358 services; 2023 $30K for 444 services; 2024 $25K for 478 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marco A Lacerda prescribed most often to Medicare patients was Tacrolimus, with 353 prescriptions and refills. In total Marco A Lacerda wrote 1,445 Medicare prescriptions that cost $363K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tacrolimus Generic | 353 | 840 | 83 | $40K |
| Mycophenolate Mofetil Generic | 93 | 235 | 26 | $12K |
| Sirolimus Generic | 80 | 186 | 18 | $44K |
| Ursodiol Generic | 80 | 199 | 23 | $22K |
| Mycophenolic Acid Mycophenolate Sodium | 68 | 184 | 21 | $40K |
| Pantoprazole Sodium Generic | 66 | 169 | 18 | $1,114 |
| Furosemide Generic | 54 | 102 | 18 | $189 |
| Xifaxan Rifaximin | 42 | 42 | Under 11 | $123K |
| Spironolactone Generic | 36 | 58 | 12 | $244 |
| Mirtazapine Generic | 33 | 49 | 11 | $485 |
| Hydroxyzine Hcl Generic | 31 | 38 | Under 11 | $1,352 |
| Carvedilol Generic | 30 | 67 | Under 11 | $148 |
| Lactulose Generic | 27 | 42 | 12 | $1,140 |
| Lamivudine Hbv Lamivudine | 24 | 72 | Under 11 | $4,964 |
| Dicyclomine Hcl Generic | 21 | 43 | Under 11 | $811 |
Brand drugs: 80 claims; generic drugs: 1,365 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marco A Lacerda $1,250 ($1,250 in general payments such as food, travel and fees) from 1 company. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $1,250.
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $1,250 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.